Preventing CVD in Patients with T2DM: How to apply novel outcome data with GLP-1 RA to clinical practice
Meeting report with video, highlights and slides of PACE-CME symposium held at EuroPrevent 2018 in Ljubljana. More to be added soon
1-3 of 3
- Preventing CVD in Patients with T2DM: How to apply novel outcome data with GLP-1 RA to clinical practiceDiabetes: How to reduce risk from a cardiovascular perspective?
Prof. Diederick Grobbee
- Preventing CVD in Patients with T2DM: How to apply novel outcome data with GLP-1 RA to clinical practicePractical management of cardiovascular risk: Lessons from latest diabetes trials
Prof. Lars Rydén
- Preventing CVD in Patients with T2DM: How to apply novel outcome data with GLP-1 RA to clinical practiceThe cardiovascular challenge for primary care in diabetes
Prof. Richard Hobbs, MD
